Improving smoking cessation for individuals with psychiatric conditions using digital tools
Increasing the population-level impact of a digital therapeutic for smokers with psychiatric illness
This study is looking at how to make a helpful online program better for people with serious mental health issues who want to quit smoking, so it can reach more folks who need it and really make a difference in their lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-11081032 on NIH RePORTER |
What this research studies
This research aims to enhance the effectiveness of a digital therapeutic designed to help smokers with serious mental illness quit smoking. It focuses on understanding how to implement this therapeutic in real-world settings, ensuring that it reaches those who need it most. The approach includes user-centered design and clinical trials to evaluate the therapeutic's efficacy, while also addressing barriers to access and treatment adoption among diverse populations. The goal is to create a more significant population-level impact on smoking cessation among individuals with psychiatric illnesses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with serious mental illness who smoke and are seeking help to quit.
Not a fit: Patients who do not smoke or those without psychiatric conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved smoking cessation rates among individuals with psychiatric conditions, enhancing their overall health and quality of life.
How similar studies have performed: Previous research has shown promise in using digital therapeutics for smoking cessation, particularly among specific populations, indicating potential for success in this approach.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Vilardaga, Roger — Wake Forest University Health Sciences
- Study coordinator: Vilardaga, Roger
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.